Corsair Capital Management L.P. Acquires New Stake in Rockwell Medical, Inc. (NASDAQ:RMTI)

Corsair Capital Management L.P. bought a new stake in Rockwell Medical, Inc. (NASDAQ:RMTI) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 75,000 shares of the company’s stock, valued at approximately $298,000.

Several other institutional investors and hedge funds also recently made changes to their positions in RMTI. Vanguard Group Inc. boosted its holdings in Rockwell Medical by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock worth $1,856,000 after buying an additional 43,302 shares during the period. Armistice Capital LLC increased its holdings in shares of Rockwell Medical by 22.5% in the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after buying an additional 592,000 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of Rockwell Medical by 877.1% in the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after buying an additional 92,189 shares during the period. Beacon Financial Advisory LLC purchased a new stake in Rockwell Medical during the 3rd quarter valued at $98,000. Finally, Verus Capital Partners LLC bought a new stake in Rockwell Medical in the 3rd quarter worth $51,000. Institutional investors own 23.31% of the company’s stock.

Rockwell Medical Trading Down 2.6 %

NASDAQ:RMTI opened at $2.25 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00. The company’s 50-day simple moving average is $3.46 and its 200 day simple moving average is $2.66. Rockwell Medical, Inc. has a one year low of $1.16 and a one year high of $5.15. The firm has a market capitalization of $72.72 million, a P/E ratio of -45.00 and a beta of 1.50.

Analysts Set New Price Targets

Several brokerages have recently commented on RMTI. StockNews.com downgraded shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. RODMAN&RENSHAW upgraded shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th. HC Wainwright cut their target price on shares of Rockwell Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday. Finally, Rodman & Renshaw started coverage on shares of Rockwell Medical in a research note on Thursday, November 14th. They issued a “buy” rating and a $5.00 price target for the company.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.